300878 维康药业
已收盘 11-13 15:00:00
资讯
新帖
简况
维康药业(300878)11月12日主力资金净卖出136.18万元
证券之星 · 09:06
维康药业(300878)11月12日主力资金净卖出136.18万元
维康药业(300878)11月10日主力资金净卖出70.14万元
证券之星 · 11-11 09:08
维康药业(300878)11月10日主力资金净卖出70.14万元
维康药业(300878)11月6日主力资金净买入1609.40万元
证券之星 · 11-09
维康药业(300878)11月6日主力资金净买入1609.40万元
维康药业新提交“-”、“十倍增芯”等2件商标注册申请
证券之星 · 11-08
维康药业新提交“-”、“十倍增芯”等2件商标注册申请
维康药业(300878)2026年三季报简析:营收上升亏损收窄,盈利能力上升
证券之星 · 10-31
维康药业(300878)2026年三季报简析:营收上升亏损收窄,盈利能力上升
维康药业(300878)9月30日股东户数0.76万户,较上期减少6.13%
证券之星 · 10-30
维康药业(300878)9月30日股东户数0.76万户,较上期减少6.13%
股市必读:维康药业新发布《公司章程(202610)》
证券之星 · 10-30
股市必读:维康药业新发布《公司章程(202610)》
图解维康药业三季报:第三季度单季净利润同比增长98.62%
证券之星 · 10-30
图解维康药业三季报:第三季度单季净利润同比增长98.62%
股市必读:维康药业新发布《关于部分募集资金专户注销的公告》
证券之星 · 10-23
股市必读:维康药业新发布《关于部分募集资金专户注销的公告》
维康药业:10月15日董事吴建明增持股份合计200股
证券之星 · 10-16
维康药业:10月15日董事吴建明增持股份合计200股
维康药业(300878)披露药品生产许可证变更公告,10月09日股价上涨1.87%
证券之星 · 10-09
维康药业(300878)披露药品生产许可证变更公告,10月09日股价上涨1.87%
维康药业(300878.SZ):黄甲软肝颗粒获批开展用于慢性乙型病毒性肝炎肝纤维化的III期临床试验
智通财经 · 09-15
维康药业(300878.SZ):黄甲软肝颗粒获批开展用于慢性乙型病毒性肝炎肝纤维化的III期临床试验
维康药业连亏3年半 2020年上市募8.3亿国联民生保荐
中金财经 · 09-11
维康药业连亏3年半 2020年上市募8.3亿国联民生保荐
维康药业(300878)披露药品生产许可证变更公告,9月10日股价下跌5.1%
证券之星 · 09-10
维康药业(300878)披露药品生产许可证变更公告,9月10日股价下跌5.1%
维康药业(300878)披露2026年半年度报告,8月31日股价上涨2.12%
证券之星 · 08-31
维康药业(300878)披露2026年半年度报告,8月31日股价上涨2.12%
维康药业(300878)2026年中报简析:营收上升亏损收窄,盈利能力上升
证券之星 · 08-30
维康药业(300878)2026年中报简析:营收上升亏损收窄,盈利能力上升
维康药业(300878)6月30日股东户数0.81万户,较上期增加8.79%
证券之星 · 08-29
维康药业(300878)6月30日股东户数0.81万户,较上期增加8.79%
维康药业(300878)披露获得药品补充申请批准通知书,8月10日股价下跌4.51%
证券之星 · 08-10
维康药业(300878)披露获得药品补充申请批准通知书,8月10日股价下跌4.51%
维康药业最新公告:金钱草胶囊获药品补充申请批准
证券之星 · 08-10
维康药业最新公告:金钱草胶囊获药品补充申请批准
维康药业(300878)披露部分募集资金专户注销公告,7月22日股价下跌0.48%
证券之星 · 07-22
维康药业(300878)披露部分募集资金专户注销公告,7月22日股价下跌0.48%
加载更多
公司概况
公司名称:
浙江维康药业股份有限公司
所属行业:
医药制造业
上市日期:
2020-08-24
主营业务:
浙江维康药业股份有限公司的主营业务是现代中药及西药的研发、生产和销售。公司的主要产品是银黄滴丸、益母草软胶囊、益母草分散片、七叶神安分散片、枫蓼肠胃康分散片、人参健脾片等中成药、罗红霉素软胶囊、灵芝孢子粉(破壁)。公司“经产良药益母草的多维评价与开发应用”荣获四川省科学技术进步奖一等奖;“浙西南特色中药材产业提升关键技术研究与示范”荣获浙江省科学技术进步奖三等奖;“银黄滴丸的二次开发研究”荣获浙江省药学会科学技术奖二等奖。截至报告期末,公司1个药品获得了浙江省高新技术产品证书,5个药品被浙江省经信委评为省级工业新产品,8个药品被登记为浙江省科学技术成果。
发行价格:
41.34
{"stockData":{"symbol":"300878","market":"SZ","secType":"STK","nameCN":"维康药业","latestPrice":33.43,"timestamp":1794553395000,"preClose":35,"halted":0,"volume":2682361,"delay":0,"changeRate":-0.0449,"floatShares":144000000,"shares":145000000,"eps":-0.8742,"marketStatus":"已收盘","change":-1.57,"latestTime":"11-13 15:00:00","open":34.42,"high":34.68,"low":32.96,"amount":91023500,"amplitude":0.0491,"askPrice":33.44,"askSize":78,"bidPrice":33.43,"bidSize":36,"shortable":0,"etf":0,"ttmEps":-0.8742,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":5,"adr":0,"adjPreClose":35,"symbolType":"stock","openAndCloseTimeList":[[1794533400000,1794540600000],[1794546000000,1794553200000]],"highLimit":38.5,"lowLimit":31.5,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":144790322,"isCdr":false,"pbRate":5.71,"roa":"--","roe":"--","epsLYR":-1.57,"committee":0.248705,"marketValue":4840000000,"turnoverRate":0.0186,"status":1,"floatMarketCap":4818000000},"requestUrl":"/m/hq/s/300878","defaultTab":"news","newsList":[{"id":"2683544309","title":"维康药业(300878)11月12日主力资金净卖出136.18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2683544309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683544309?lang=zh_cn&edition=full","pubTime":"2026-11-13 09:06","pubTimestamp":1794532007,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月12日收盘,维康药业报收于35.0元,上涨1.69%,换手率3.17%,成交量4.56万手,成交额1.58亿元。近5日资金流向一览见下表:维康药业融资融券信息显示,融资方面,当日融资买入801.5万元,融资偿还1296.11万元,融资净偿还494.61万元。维康药业主营业务:现代中药及西药的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300010006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682632387","title":"维康药业(300878)11月10日主力资金净卖出70.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682632387","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682632387?lang=zh_cn&edition=full","pubTime":"2026-11-11 09:08","pubTimestamp":1794359320,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月10日收盘,维康药业报收于33.56元,上涨5.83%,换手率3.07%,成交量4.42万手,成交额1.46亿元。近5日资金流向一览见下表:维康药业融资融券信息显示,融资方面,当日融资买入606.24万元,融资偿还756.91万元,融资净偿还150.66万元。维康药业主营业务:现代中药及西药的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100014300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682990822","title":"维康药业(300878)11月6日主力资金净买入1609.40万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682990822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682990822?lang=zh_cn&edition=full","pubTime":"2026-11-09 09:03","pubTimestamp":1794186236,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月6日收盘,维康药业报收于31.3元,上涨9.44%,换手率3.29%,成交量4.74万手,成交额1.43亿元。近5日资金流向一览见下表:维康药业融资融券信息显示,融资方面,当日融资买入1694.15万元,融资偿还1346.9万元,融资净买入347.25万元。维康药业主营业务:现代中药及西药的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900002017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681422408","title":"维康药业新提交“-”、“十倍增芯”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2681422408","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681422408?lang=zh_cn&edition=full","pubTime":"2026-11-08 16:25","pubTimestamp":1794126355,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日浙江维康药业股份有限公司新提交“-”、“十倍增芯”等2件商标注册申请。商标申请详情如下:今年以来浙江维康药业股份有限公司新申请注册商标2件,截止目前公司共持有注册商标170件,另有14件商标尚在注册申请中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110800003332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679222440","title":"维康药业(300878)2026年三季报简析:营收上升亏损收窄,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2679222440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679222440?lang=zh_cn&edition=full","pubTime":"2026-10-31 11:55","pubTimestamp":1793418911,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期维康药业发布2026年三季报。截至本报告期末,公司营业总收入1.78亿元,同比上升17.86%,归母净利润-2307.79万元,同比上升81.37%。本报告期维康药业盈利能力上升,毛利率同比增幅156.05%,净利率同比增幅84.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100025691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679158522","title":"维康药业(300878)9月30日股东户数0.76万户,较上期减少6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679158522","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679158522?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:28","pubTimestamp":1793359717,"startTime":"0","endTime":"0","summary":"证券之星消息,近日维康药业披露,截至2026年9月30日公司股东户数为7609.0户,较6月30日减少497.0户,减幅为6.13%。在中药行业个股中,维康药业股东户数低于行业平均水平,截至9月30日,中药行业平均股东户数为5.33万户。从股价来看,2026年6月30日至2026年9月30日,维康药业区间跌幅为6.71%,在此期间股东户数减少497.0户,减幅为6.13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000047955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679258323","title":"股市必读:维康药业新发布《公司章程(202610)》","url":"https://stock-news.laohu8.com/highlight/detail?id=2679258323","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679258323?lang=zh_cn&edition=full","pubTime":"2026-10-30 06:56","pubTimestamp":1793314618,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘,维康药业报收于27.91元,下跌4.16%,换手率0.83%,成交量1.2万手,成交额3407.89万元。公司公告汇总:维康药业拟将2024年回购的2,739,026股股份用途由“用于员工持股计划或股权激励”变更为“用于注销并减少注册资本”,尚需提交股东会审议。公司公告汇总关于变更回购股份用途并注销的公告浙江维康药业股份有限公司于2026年10月29日召开第四届董事会第十三次会议,审议通过《关于变更回购股份用途并注销的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000012764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679849233","title":"图解维康药业三季报:第三季度单季净利润同比增长98.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679849233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679849233?lang=zh_cn&edition=full","pubTime":"2026-10-30 03:13","pubTimestamp":1793301216,"startTime":"0","endTime":"0","summary":"证券之星消息,维康药业2026年三季报显示,前三季度公司主营收入1.78亿元,同比上升17.86%;归母净利润-2307.79万元,同比上升81.37%;扣非净利润-2313.51万元,同比上升81.07%;其中2026年第三季度,公司单季度主营收入5218.59万元,同比上升42.01%;单季度归母净利润-82.23万元,同比上升98.62%;单季度扣非净利润-301.45万元,同比上升94.74%;负债率28.91%,投资收益-15.03万元,财务费用335.3万元,毛利率39.29%。财报数据概要请见下图:本文数据来源于维康药业2026年三季报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000005717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677996558","title":"股市必读:维康药业新发布《关于部分募集资金专户注销的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677996558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677996558?lang=zh_cn&edition=full","pubTime":"2026-10-23 04:02","pubTimestamp":1792699335,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘,维康药业报收于28.23元,下跌0.14%,换手率0.81%,成交量1.17万手,成交额3303.1万元。当日关注点交易信息汇总:10月22日主力资金净流入204.61万元,占总成交额6.19%。公司公告汇总:维康药业注销上海浦东发展银行丽水分行募集资金专户,将“营销网络中心建设项目”剩余募集资金1,355.09万元永久补充流动资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300004235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675080592","title":"维康药业:10月15日董事吴建明增持股份合计200股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675080592","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675080592?lang=zh_cn&edition=full","pubTime":"2026-10-16 21:01","pubTimestamp":1792155681,"startTime":"0","endTime":"0","summary":"证券之星消息,根据10月16日市场公开信息、上市公司公告及交易所披露数据整理,维康药业(300878)最新董监高及相关人员股份变动情况:2026年10月15日公司董事吴建明共增持公司股份200.0股,占公司总股本为0.0001%。变动期间公司股价下跌2.47%,10月15日当日收盘报27.69元。维康药业近半年内的董监高及核心技术人员增减持详情如下:维康药业的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出422.95万,融资余额减少;融券净流入0.0,融券余额增加。该股最近90天内无机构评级。本文数据来源于深圳证券交易所信息披露、维康药业公告,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600038302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674534788","title":"维康药业(300878)披露药品生产许可证变更公告,10月09日股价上涨1.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674534788","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674534788?lang=zh_cn&edition=full","pubTime":"2026-10-09 18:13","pubTimestamp":1791540829,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘,维康药业报收于29.9元,较前一交易日上涨1.87%,最新总市值为43.29亿元。该股当日开盘29.29元,最高29.99元,最低28.28元,成交额达4459.97万元,换手率为1.06%。公司于2026年10月8日披露《关于公司药品生产许可证变更的公告》。公告显示,浙江维康药业股份有限公司取得浙江省药品监督管理局换发的《药品生产许可证》,主要变更受托生产事项。本次变更短期内对公司业绩无重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900029919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667832610","title":"维康药业(300878.SZ):黄甲软肝颗粒获批开展用于慢性乙型病毒性肝炎肝纤维化的III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832610","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667832610?lang=zh_cn&edition=full","pubTime":"2026-09-15 16:15","pubTimestamp":1789460131,"startTime":"0","endTime":"0","summary":"智通财经APP讯,维康药业(300878.SZ)发布公告,公司于近日收到国家药品监督管理局核准签发的黄甲软肝颗粒的《药物临床试验补充申请批准通知书》,经审查,黄甲软肝颗粒临床试验申请符合药品注册的有关要求,在进一步完善临床试验方案的基础上,同意开展用于慢性乙型病毒性肝炎肝纤维化的III期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBJ","IBBQ","BMED","MDTX","PSYK","BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666254772","title":"维康药业连亏3年半 2020年上市募8.3亿国联民生保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2666254772","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666254772?lang=zh_cn&edition=full","pubTime":"2026-09-11 16:46","pubTimestamp":1789116364,"startTime":"0","endTime":"0","summary":"中国经济网北京9月11日讯 维康药业 日前披露2026年半年度报告。今年上半年,公司实现营业收入1.26亿元,同比增长10.11%;归属于上市公司股东的净利润为-2225.56万元;归属于上市公司股东的扣除非经常性损益的净利润为-2012.06万元;经营活动产生的现金流量净额为-2462.41万元。 维康药业于上市次日即2020年8月25日创下截至目前的股价最高点109.80元。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/11/20260911608573.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/11/20260911608573.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260911/32367445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1564","601456","IPOS","300878","BK0276","BK0239","01456","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666956262","title":"维康药业(300878)披露药品生产许可证变更公告,9月10日股价下跌5.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666956262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666956262?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:11","pubTimestamp":1789035093,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘,维康药业报收于33.15元,较前一交易日下跌5.1%,最新总市值为48亿元。该股当日开盘35.28元,最高35.36元,最低32.67元,成交额达1.04亿元,换手率为2.15%。公司于近日取得浙江省药品监督管理局换发的《药品生产许可证》,生产负责人由丁京伟变更为孟召光。本次变更系基于公司日常经营管理需要,已依法完成相关手续。本次变更不会对公司正常生产经营及经营业绩产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000034565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663072511","title":"维康药业(300878)披露2026年半年度报告,8月31日股价上涨2.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663072511","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663072511?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:34","pubTimestamp":1788172445,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,维康药业报收于32.68元,较前一交易日上涨2.12%,最新总市值为47.32亿元。该股当日开盘31.2元,最高33.3元,最低31.01元,成交额达1.37亿元,换手率为2.94%。近日,维康药业披露《2026年半年度报告》。报告显示,公司2026年上半年营业收入为126,158,518.77元,较上年同期增长10.11%;归属于上市公司股东的净利润为-22,255,603.93元,同比亏损收窄65.34%;扣除非经常性损益后的净利润为-20,120,582.37元,同比改善68.96%。经营活动产生的现金流量净额为-24,624,078.54元,同比下降155.45%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100029122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663774048","title":"维康药业(300878)2026年中报简析:营收上升亏损收窄,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663774048","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663774048?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:31","pubTimestamp":1788042706,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期维康药业发布2026年中报。截至本报告期末,公司营业总收入1.26亿元,同比上升10.11%,归母净利润-2225.56万元,同比上升65.34%。本报告期维康药业盈利能力上升,毛利率同比增幅84.79%,净利率同比增幅68.64%。),公司上市来已有年报6份,亏损年份3次,显示生意模式比较脆弱。财报体检工具显示:建议关注公司现金流状况建议关注公司应收账款状况本文数据来源于维康药业2026年中报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012486","title":"维康药业(300878)6月30日股东户数0.81万户,较上期增加8.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012486","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012486?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:19","pubTimestamp":1787995162,"startTime":"0","endTime":"0","summary":"证券之星消息,近日维康药业披露,截至2026年6月30日公司股东户数为8106.0户,较3月31日增加655.0户,增幅为8.79%。在中药行业个股中,维康药业股东户数低于行业平均水平,截至6月30日,中药行业平均股东户数为5.16万户。从股价来看,2026年3月31日至2026年6月30日,维康药业区间涨幅为17.56%,在此期间股东户数增加655.0户,增幅为8.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658932976","title":"维康药业(300878)披露获得药品补充申请批准通知书,8月10日股价下跌4.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658932976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658932976?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:23","pubTimestamp":1786371797,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘,维康药业报收于33.27元,较前一交易日下跌4.51%,最新总市值为48.17亿元。公司于近日披露《关于获得药品补充申请批准通知书的公告》。公告显示,浙江维康药业股份有限公司收到国家药品监督管理局核准签发的药品补充申请批准通知书,批准金钱草胶囊变更药品说明书中安全性等内容,以及变更制剂处方中的辅料。注册标准执行国家药品标准及此前的补充申请要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000034225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658934537","title":"维康药业最新公告:金钱草胶囊获药品补充申请批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2658934537","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658934537?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:43","pubTimestamp":1786369402,"startTime":"0","endTime":"0","summary":"维康药业(300878.SZ)公告称,公司近日收到国家药品监督管理局核准签发的金钱草胶囊药品补充申请批准通知书,批准变更药品说明书中安全性内容及制剂处方中的辅料,并同意新增浙江维康瓯江胶囊有限公司的明胶空心胶囊在该品中使用。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000032938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653766692","title":"维康药业(300878)披露部分募集资金专户注销公告,7月22日股价下跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653766692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653766692?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:32","pubTimestamp":1784730739,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘,维康药业报收于27.17元,较前一交易日下跌0.48%,最新总市值为39.34亿元。该股当日开盘27.28元,最高28.87元,最低26.87元,成交额达1.21亿元,换手率为3.02%。公司于近日披露《关于部分募集资金专户注销的公告》。公告显示,浙江维康药业股份有限公司因使用部分超募资金永久补充流动资金,已于2026年7月22日完成对中国农业银行股份有限公司丽水莲都支行募集资金专户的注销,账户余额已转至公司基本账户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200047613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794581679073,"stockEarnings":[{"period":"1week","weight":0.2238},{"period":"1month","weight":0.2094},{"period":"3month","weight":0.0086},{"period":"6month","weight":-0.0331},{"period":"1year","weight":0.2187},{"period":"ytd","weight":0.372}],"compareEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":-0.0382},{"period":"3month","weight":-0.0691},{"period":"6month","weight":-0.116},{"period":"1year","weight":-0.0861},{"period":"ytd","weight":-0.0789}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江维康药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7609人(较上一季度减少6.13%)","perCapita":"18941股","listingDate":"2020-08-24","address":"浙江省丽水市莲都区经济开发区遂松路2号","registeredCapital":"14479万元","survey":" 浙江维康药业股份有限公司的主营业务是现代中药及西药的研发、生产和销售。公司的主要产品是银黄滴丸、益母草软胶囊、益母草分散片、七叶神安分散片、枫蓼肠胃康分散片、人参健脾片等中成药、罗红霉素软胶囊、灵芝孢子粉(破壁)。公司“经产良药益母草的多维评价与开发应用”荣获四川省科学技术进步奖一等奖;“浙西南特色中药材产业提升关键技术研究与示范”荣获浙江省科学技术进步奖三等奖;“银黄滴丸的二次开发研究”荣获浙江省药学会科学技术奖二等奖。截至报告期末,公司1个药品获得了浙江省高新技术产品证书,5个药品被浙江省经信委评为省级工业新产品,8个药品被登记为浙江省科学技术成果。","listedPrice":41.34},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"维康药业(300878)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供维康药业(300878)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"维康药业,300878,维康药业股票,维康药业股票老虎,维康药业股票老虎国际,维康药业行情,维康药业股票行情,维康药业股价,维康药业股市,维康药业股票价格,维康药业股票交易,维康药业股票购买,维康药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"维康药业(300878)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供维康药业(300878)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}